Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PW Medtech GroupFRA:PWE -0.97%57 Receivables Turnover is 5.46 as of Dec. 2025. GuruFocus rates FRA:PWE with a GF Score™ of 57/100 and a GF Value™ of €0.14 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 812 Medical Devices & Instruments companies, PW Medtech Group ranks better than 90.27% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. PW Medtech Group's Revenue for the
six
months ended in Dec. 2025 was €49.61 Mil. PW Medtech Group's average Accounts Receivable for the
six
months ended in Dec. 2025 was €9.08 Mil.
Hence, PW Medtech Group's Receivables Turnover for the
six
months ended in Dec. 2025 was 5.46.
PW Medtech Group (FRA:PWE) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
PW Medtech Group Receivables Turnover Related Terms
PW Medtech Group Receivables Turnover Historical Data
* Premium members only.
The historical data trend for PW Medtech Group's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PWE vs ISRG, BDX, MDLN: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, PW Medtech Group's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group (FRA:PWE) has a Receivables Turnover of 5.46 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PW Medtech Group and its competitors. According to the industry distribution chart, PW Medtech Group ranks #79 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 9.7%.
Is PW Medtech Group's Receivables Turnover too high?
PW Medtech Group's current Receivables Turnover is 5.46. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. PW Medtech Group's value of 5.46 is 0.9% below this industry median. Based on the distribution chart, PW Medtech Group ranks #79 out of 812 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PW Medtech Group has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PW Medtech Group ranks #79 out of 812 companies for Receivables Turnover. This places PW Medtech Group in the top 10% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.51. PW Medtech Group's value of 5.46 is 0.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PW Medtech Group's current Receivables Turnover of 5.46 is 0.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PW Medtech Group and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PW Medtech Group's current Receivables Turnover is 5.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
Based on GuruFocus' analysis, PW Medtech Group (FRA:PWE) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.14, compared to a current price of €0.10 — trading 27.1% below its estimated fair value. The current Receivables Turnover is 5.46 and 0.9% below the Medical Devices & Instruments industry median of 5.51. PW Medtech Group's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current Receivables Turnover is 5.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PW Medtech Group (FRA:PWE) Overvalued in 2026?
Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued.
The current stock price of €0.10 is trading 27.1% below its estimated GF Value™ of €0.14.
GuruFocus considers PW Medtech Group to be Modestly Undervalued.
Key valuation signals for FRA:PWE:
Receivables Turnover: 5.46
GF Value™: €0.14 vs. price of €0.10 (27.1% below fair value)
Industry Position: 0.9% below the Medical Devices & Instruments median (#79 of 812)
No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
57GF Score
Get the complete analysis for FRA:PWE
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PWE has been successfully added to your 
